a2-antiplasmin or PAI-1. Rare bleeding disorders deficiency of factor I II V V&VIII VII X XI XIII
Conditions
Interventions
Sponsors
Radboud Universitair Medisch Centrum
Eligibility
Age
2 Years to 64 Years
Inclusion criteria
Inclusion criteria: Rare bleeding disorder Age 1-99
Exclusion criteria
Exclusion criteria: No informed consent Residency outside of the Netherlands
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Description of the clinical phenotype, laboratory phenotype, genotype and quality of life of patients with rare bleeding disorders | — |
Countries
The Netherlands
Outcome results
None listed